£2.5m to help Newcastle biotech firm launch world-first skin cancer test in the UK and USA

Share On LinkedIn
Share on X
£2.5m to help Newcastle biotech firm launch world-first skin cancer test in the UK and USA

Newcastle Uni spin-out company AMLo Biosciences has received almost £2.5m to help it launch a new skin cancer test which could help reduce the mammoth pressure on the NHS.

STORY OF THE WEEK

Technology PR, search and social agency

Trending Now

Leave a Reply

Your email address will not be published. Required fields are marked *